Rakesh Shah, a shareholder of Eris Lifesciences, has divested a 1.5% stake in the company for Rs 200 crore through an open market transaction. The shares were offloaded at an average price of Rs 1,000.12 per piece, taking the deal value to Rs 200.02 crore.
New Delhi, Jul 15 (PTI) Eris Lifesciences shareholder Rakesh Shah on Monday divested a 1.5 per cent stake in the company for Rs 200 crore through an open market transaction.
According to the bulk deal data available on the National Stock Exchange (NSE), Shah sold 20 lakh shares or 1.5 per cent stake in Eris Lifesciences.
The shares were offloaded at an average price of Rs 1,000.12 per piece, taking the deal value to Rs 200.02 crore.
After the transaction, Shah's stake in Ahmedabad-based Eris Lifesciences came down to 3.38 per cent from 4.88 per cent.
Meanwhile, Franklin Templeton Mutual Fund picked up 10.94 lakh shares of Eris Lifesciences at at an average price of Rs 1,000.04 apiece.
This took the transaction value to Rs 109.42 crore. However, other buyers of Eris Lifesciences' shares could not be ascertained.
The scrip of Eris Lifesciences fell 2.80 per cent to settle at Rs 1,014 apiece on the NSE.
In July 2023, Shah pared a 2 per cent stake in Eris Lifesciences for Rs 188.19 crore.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback